New insights into the underlying mechanisms of Type 2 diabetes and novel potential therapeutic targets for the disease were revealed in a recent study by a team of Texas A&M AgriLife Research ...
For the first time, scientists showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes. For the first time, scientists at the Toronto General Research ...
BIRMINGHAM, Ala. - The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment for diabetes. Tested on isolated ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
Boehringer Ingelheim and Zealand Pharma A/S have announced that Boehringer Ingelheim plans to initiate phase 2 development of the GLP-1/glucagon dual agonist BI 456906, which was in-licensed from ...
Wanbao Yang, Ph.D., (left) graduate student and the study’s first author, and Shaodong Guo, Ph.D., who served as its principal investigator. (Texas A&M AgriLife photo by Tyler Morales) The study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback